Jeffrey Bluestone insider trades: Gilead Sciences (GILD) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jeffrey reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 20, 2026 | GILD | ↓ Sell | 5,000 | $145.02 | $725K | Direct | Aug 21, 2026 (1d) |
| Jan 20, 2026 | GILD | ↓ Sell | 5,000 | $123.50 | $618K | Direct | Jan 21, 2026 (1d) |
| Nov 28, 2025 | GILD | ↓ Sell | 5,000 | $125.08 | $625K | Direct | Dec 1, 2025 (3d) |
| Jul 14, 2025 | GILD | ↓ Sell | 5,000 | $109.74 | $549K | Direct | Jul 15, 2025 (1d) |
| Nov 26, 2024 | GILD | ↓ Sell | 6,788 | $91.39 | $620K | Direct | Nov 27, 2024 (1d) |
| Jun 17, 2019 | PRVB | ↓ Sell | 7,300 | $11.93 | $87K | Direct | Jun 17, 2019 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other GILD insiders
Open-market trades in the last 12 months
About Jeffrey Bluestone's insider trades
Jeffrey Bluestone is a director at Gilead Sciences (GILD). Since Jun 17, 2019, Jeffrey has reported no open-market purchases and 6 sales worth $3.2M on SEC Form 4. In the last 12 months: 3 sales ($2.0M).
Their filings also include grants and awards (11 filings), option exercises (8 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GILD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.